Cost intelligence, PBM strategies, and pharmacy benefit management for employers and HR teams.
Employers in 2026 are saving millions by steering Humira, Stelara, and Eylea claims to biosimilars while confronting PBM rebate pressure and formulary barriers.
April 25, 2026 Benefits GuideHow to assess carve-in PBM models in 2026 by aligning medical and pharmacy data without giving up rebate transparency or cost control.
April 20, 2026 Pharmacy CostsEmployers are ditching spread pricing PBMs in 2026 for transparent, pass-through contracts to recover hidden pharmacy dollars and cut true net costs.
April 18, 2026 Benefits GuideHow employers in 2026 can manage rising GLP‑1 drug costs with smart plan design, clinical criteria, and employee communication strategies.
April 15, 2026 Cost ControlHow to design generic substitution policies that lower pharmacy costs without disrupting employees: best practices for step therapy, therapeutic interchange, and quantity limits.
April 7, 2026 ConditionsMany mid-size employers exclude drugs to cut pharmacy costs, but blanket exclusions can backfire. Learn how to tailor exclusions for cost and employee impact.
April 6, 2026 Employee CommsPractical steps for HR and benefits leaders to help employees access manufacturer drug copay assistance and patient assistance programs, with real-world examples.
April 2, 2026 Benefits GuideShould you carve pharmacy out from your medical plan? Real numbers, pitfalls, and the exact steps to decide if a carve-out saves money for your company.
March 31, 2026 Cost ControlMandatory mail-order pharmacy programs can deliver savings, but real-world data shows trade-offs with employee satisfaction. Here’s what works, what doesn’t, and how to decide.
March 26, 2026 Pharmacy CostsPrior authorizations may control drug spend, but hidden costs from administrative burden and treatment delays can quietly erode expected savings for employers.
March 25, 2026 Benefits GuideHow to tell real pharmacy benefits consulting apart from PBM sales spin, with hard questions, benchmarks, and one must-do step for HR and benefit managers.
March 24, 2026 TransparencyCMS Transparency in Coverage files expose your pharmacy pricing and PBM contract quirks. Here’s what employers see, and how to use (or misuse) the data.
March 23, 2026 Employee CommsStrategies, templates, and timing tips for HR and benefits leaders to communicate pharmacy benefit changes without employee backlash. Real-world tactics inside.
March 19, 2026 Plan DesignFormulary tweaks can trim pharmacy spend by 8-15%, but missteps spark employee noise. Here’s how to save money without spiking complaints or HR headaches.
March 18, 2026 Benefits GuidePBM RFPs can get messy fast. Here’s how to ask the right questions, demand real guarantees, and make valid comparisons, without missing the practical details.
March 17, 2026 Specialty DrugsSite-of-care strategies can cut specialty drug infusion costs by 50% or more. See real numbers, PBM tactics, and pitfalls for mid- and large employers.
March 16, 2026 Pbm ContractsAn overlooked PBM contract clause cost a 550-life manufacturer $312,000 last year. Read how fine print can add six figures to mid-market pharmacy spend.
March 15, 2026 Benefits GuideLearn practical steps to benchmark your pharmacy spend using PMPM, GDR, specialty share, and mail-order rates for informed benefits management.
March 14, 2026 Pharmacy CostsDiscover why your pharmacy PEPM spend might be higher than expected and uncover common areas where money leaks in your pharmacy benefits plan.
March 14, 2026 Pbm ContractsPBM rebates can look like big savings, but most employers see far less than manufacturers pay. Here’s how rebate dollars really flow, and what plans can do.
March 11, 2026 Data AnalyticsMany employers miss six-figure pharmacy savings by not reviewing these five core claims reports each quarter. Here’s how to spot waste and act on it.
March 5, 2026 Pharmacy CostsShould your 200-2,000 life company self-fund pharmacy benefits or stay fully insured? Real-world cost comparisons plus practical advice from a pharmacy benefits consultant.
February 25, 2026 RegulationWhat the Inflation Reduction Act really means for employer pharmacy plans: $2,000 out-of-pocket cap, $35 insulin, and what HR leaders need to prepare for next.
February 17, 2026 BiosimilarsBiosimilar adoption is delivering 40–70% savings on biologics for employers. Which drug classes now offer real alternatives, and where do the biggest opportunities lie?
February 7, 2026 TransparencyPass-through and spread pricing in PBM contracts can swing costs by six figures. See the math, pros, and pitfalls before you make the switch.
January 30, 2026 Specialty DrugsSpecialty drugs now account for over half of employer pharmacy spend. Here’s what HR and benefits leaders can do to control costs without sacrificing care.
January 22, 2026 Plan DesignAvoid costly plan design mistakes in 2026 pharmacy benefits. Get real advice on copays, coinsurance, and specialty carve-outs that actually reduce spend.
January 14, 2026 Pharmacy CostsOne mid-sized employer spent $320,000 on GLP-1s in 2023. Here’s how benefits leaders are reining in semaglutide and tirzepatide costs, without excluding coverage.
January 6, 2026